MFS Blended Research® Emerging Markets Equity (BREE) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
MFS Blended Research® Emerging Markets Equity (BREE) operates in the Financial Services sector, specifically the Asset Management - Global industry, with a market capitalization near $18.5M, listed on NYSE, carrying a beta of 0.00 to the broader market. BREE invests primarily in equities of companies tied economically to emerging market countries across regions such as Asia, Latin America, Eastern Europe, the Middle East, and Africa. Led by Matthew W. Krummell, public since 2026-03-05.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for BREE as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.